These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34200772)

  • 21. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
    PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
    Ahluwalia B; Magnusson MK; Böhn L; Störsrud S; Larsson F; Savolainen O; Ross A; Simrén M; Öhman L
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13860. PubMed ID: 32314514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
    Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
    BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 26. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome.
    Jalanka-Tuovinen J; Salojärvi J; Salonen A; Immonen O; Garsed K; Kelly FM; Zaitoun A; Palva A; Spiller RC; de Vos WM
    Gut; 2014 Nov; 63(11):1737-45. PubMed ID: 24310267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study.
    Altomare A; Del Chierico F; Rocchi G; Emerenziani S; Nuglio C; Putignani L; Angeletti S; Lo Presti A; Ciccozzi M; Russo A; Cocca S; Ribolsi M; Muscaritoli M; Cicala M; Guarino MPL
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33925672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients.
    Liu T; Gu X; Li LX; Li M; Li B; Cui X; Zuo XL
    BMC Microbiol; 2020 Jun; 20(1):168. PubMed ID: 32552668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.
    Bennet SMP; Sundin J; Magnusson MK; Strid H; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13468. PubMed ID: 30230134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
    Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
    Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: Relations to subtype.
    Teige ES; Hillestad EMR; Steinsvik EK; Brønstad I; Lundervold A; Lundervold AJ; Valeur J; Hausken T; Berentsen B; Lied GA
    Neurogastroenterol Motil; 2024 Sep; 36(9):e14854. PubMed ID: 38946176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiomics Analysis Reveals Gut Virome-Bacteria-Metabolite Interactions and Their Associations with Symptoms in Patients with IBS-D.
    Xie P; Luo M; Fan J; Xiong L
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.
    Yu LM; Zhao KJ; Wang SS; Wang X; Lu B
    World J Gastroenterol; 2018 Feb; 24(8):894-904. PubMed ID: 29491683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.